* 26 scientific abstracts, including two oral presentations, demonstrate?UCB's ongoing commitment to advancing research for people living with epilepsies * Data include an open-label extension study describing the long-term safety of?FINTEPLA?▼?(fenfluramine)[1] and global functioning in chil...
2025-08-29 14:00
1924